Management of patients with heart failure with preserved ejection fraction: what do patients and providers need and want?

Not Applicable

Completed

• Conditions: Heart failure with preserved ejection fraction, impact of COVID-19 (SARS-CoV-2 infection) pandemic on healthcare received and provided; Circulatory System; Heart failure

• Registration Number: ISRCTN13471603
• Lead Sponsor: Cambridge University Hospitals NHS Foundation Trust

Brief Summary

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33139334/ (added 18/05/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33401942/ (added 18/05/2021) 2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31772040/ (added 05/10/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-06-17
• Study Completion: 2020-11-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

This is a recall study: patients, carers and healthcare professionals who participated in OPTIMISE HFpEF (https://clinicaltrials.gov/ct2/show/NCT03617848) and provided 'consent to be contacted' will be invited to participate

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Perspectives on care provided and received since COVID-19, assessed using interview and survey at a single timepoint (baseline)

Secondary Outcome Measures

Name	Time	Method
There are no secondary outcome measures